Cargando…
Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer
We report on a predictive model of long-term outcome in 114 high-risk breast cancer patients treated with high-dose chemotherapy between 1989 and 1994. Paraffin-blocks from 90 of the 114 primaries were assessed for the presence of five risk factors: grade, mitotic index, protein expression of p53, H...
Autores principales: | Somlo, G, Simpson, J F, Frankel, P, Chow, W, Leong, L, Margolin, K, Morgan, R, Raschko, J, Shibata, S, Forman, S, Kogut, N, McNamara, M, Molina, A, Somlo, E, Doroshow, J H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364229/ https://www.ncbi.nlm.nih.gov/pubmed/12177795 http://dx.doi.org/10.1038/sj.bjc.6600450 |
Ejemplares similares
-
High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome
por: Somlo, G, et al.
Publicado: (2001) -
Oligometastatic Breast Cancer Patients Treated with High-Dose Chemotherapy and Targeted Radiation: Long-Term Follow-Up of a Phase II Trial
por: Ladbury, Colton, et al.
Publicado: (2022) -
Metaplastic Breast Carcinoma in the Lungs: A Case Report
por: Bourdeanu, Laura, et al.
Publicado: (2013) -
Cyst growth, polycystins, and primary cilia in autosomal dominant polycystic kidney disease
por: Lee, Seung Hun, et al.
Publicado: (2014) -
Appropriateness of granulocyte colony-stimulating factor use in
patients receiving chemotherapy by febrile neutropenia risk
level
por: Baig, Hassam, et al.
Publicado: (2018)